These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37319369)

  • 41. Systematic design of cell membrane coating to improve tumor targeting of nanoparticles.
    Liu L; Pan D; Chen S; Martikainen MV; Kårlund A; Ke J; Pulkkinen H; Ruhanen H; Roponen M; Käkelä R; Xu W; Wang J; Lehto VP
    Nat Commun; 2022 Oct; 13(1):6181. PubMed ID: 36261418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inside-Out-Oriented Cell Membrane Biomimetic Magnetic Nanoparticles for High-Performance Drug Lead Discovery.
    Bu Y; Zhang X; Zhu A; Li L; Xie X; Wang S
    Anal Chem; 2021 Jun; 93(22):7898-7907. PubMed ID: 34038073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease.
    Zhong X; Na Y; Yin S; Yan C; Gu J; Zhang N; Geng F
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Nanodecoys" - Future of drug delivery by encapsulating nanoparticles in natural cell membranes.
    Imran M; Jha LA; Hasan N; Shrestha J; Pangeni R; Parvez N; Mohammed Y; Jha SK; Paudel KR
    Int J Pharm; 2022 Jun; 621():121790. PubMed ID: 35504432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.
    Luk BT; Jiang Y; Copp JA; Hu CJ; Krishnan N; Gao W; Li S; Fang RH; Zhang L
    Mol Pharm; 2018 Sep; 15(9):3723-3728. PubMed ID: 29533668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances.
    Zhang E; Phan P; Zhao Z
    Acta Pharm Sin B; 2023 May; 13(5):1789-1827. PubMed ID: 37250173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy.
    Wang D; Liu C; You S; Zhang K; Li M; Cao Y; Wang C; Dong H; Zhang X
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41138-41147. PubMed ID: 32830477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface-Layer Protein-Enhanced Immunotherapy Based on Cell Membrane-Coated Nanoparticles for the Effective Inhibition of Tumor Growth and Metastasis.
    Wu M; Liu X; Bai H; Lai L; Chen Q; Huang G; Liu B; Tang G
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9850-9859. PubMed ID: 30788951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microfluidic Sonication To Assemble Exosome Membrane-Coated Nanoparticles for Immune Evasion-Mediated Targeting.
    Liu C; Zhang W; Li Y; Chang J; Tian F; Zhao F; Ma Y; Sun J
    Nano Lett; 2019 Nov; 19(11):7836-7844. PubMed ID: 31597431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erythrocyte-Cancer Hybrid Membrane Camouflaged Hollow Copper Sulfide Nanoparticles for Prolonged Circulation Life and Homotypic-Targeting Photothermal/Chemotherapy of Melanoma.
    Wang D; Dong H; Li M; Cao Y; Yang F; Zhang K; Dai W; Wang C; Zhang X
    ACS Nano; 2018 Jun; 12(6):5241-5252. PubMed ID: 29800517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
    Hussain Z; Rahim MA; Jan N; Shah H; Rawas-Qalaji M; Khan S; Sohail M; Thu HE; Ramli NA; Sarfraz RM; Abourehab MAS
    J Control Release; 2021 Jul; 335():130-157. PubMed ID: 34015400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications.
    Wang Y; Zhang K; Li T; Maruf A; Qin X; Luo L; Zhong Y; Qiu J; McGinty S; Pontrelli G; Liao X; Wu W; Wang G
    Theranostics; 2021; 11(1):164-180. PubMed ID: 33391468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy.
    Ren H; Liu J; Li Y; Wang H; Ge S; Yuan A; Hu Y; Wu J
    Acta Biomater; 2017 Sep; 59():269-282. PubMed ID: 28663143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetically engineered cellular nanoparticles for biomedical applications.
    Krishnan N; Peng FX; Mohapatra A; Fang RH; Zhang L
    Biomaterials; 2023 May; 296():122065. PubMed ID: 36841215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform.
    Guo Q; Wang S; Xu R; Tang Y; Xia X
    RSC Adv; 2024 Mar; 14(15):10608-10637. PubMed ID: 38567339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry.
    Gheibi Hayat SM; Bianconi V; Pirro M; Sahebkar A
    Int J Pharm; 2019 Oct; 569():118628. PubMed ID: 31421198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery.
    Lee NH; You S; Taghizadeh A; Taghizadeh M; Kim HS
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy.
    Kunde SS; Wairkar S
    Int J Pharm; 2021 Apr; 598():120395. PubMed ID: 33639226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.